ALBUFUSE
LIVE

Serial Number

78429348

Owner

NOVOZYMES BIOPHARMA UK LIMITED

Attorney

Vincent O. Wagner

Filing Date

Jun 3, 2004

Add to watchlist:

No watchlists yet
View on USPTO

ALBUFUSE Trademark

Serial Number: 78429348 • Registration: 3134913

ALBUFUSE is a trademark filed by NOVOZYMES BIOPHARMA UK LIMITED on June 3, 2004. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NOVOZYMES BIOPHARMA UK LIMITED (8 trademarks)

CASTLE COURT
NOTTINGHAM, NG7 1FD , GB

Entity Type: 03

NOVOZYMES DELTA LIMITED (5 trademarks)

CASTLE COURT
NOTTINGHAM NG7 1FD , GB

Entity Type: 03

ALBUMEDIX A/S (13 trademarks)

LOTTENBORGVEJ 26
LYNGBY , DK

Entity Type: 11

NOVOZYMES BIOPHARMA DK A/S (8 trademarks)

KrogshĂžjvej 36

Entity Type: 99

DELTA BIOTECHNOLOGY LIMITED (15 trademarks)

CASTLE COURT
NOTTINGHAM NG7 1FD , GB

Entity Type: 11

Trademark Details

Filing Date

June 3, 2004

Registration Date

August 29, 2006

Published for Opposition

February 28, 2006

Goods & Services

[ Diagnostic reagents for clinical or medical laboratory use; contrasting agents for ultrasound diagnostic imaging; diagnostic imaging agents for the detection of the presence, location and extent of cancer; macro-aggregated albumin for in-vivo imaging, namely, lung imaging, shunt imaging and isotopic venography ]

[ Reagents for scientific or research use; reagents for chemical analysis; protein arrays and nucleotide arrays for scientific and medical research; chemical preparations for use in agriculture, horticulture and forestry, namely, chemical preparations for the treatment of seeds; and chemicals, namely, proteins and nucleic acids for use in the manufacture of pharmaceuticals, feed, foods and plants ]

Pharmaceutical research and development; [ professional consulting services and advice about agriculture chemistry; ] advisory services in the fields of science, biotechnology, biochemistry, biology and pharmaceuticals

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 29, 2025 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 28, 2017 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 12, 2017 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Dec 1, 2016 NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Nov 10, 2016 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Nov 10, 2016 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 10, 2016 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 9, 2016 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 29, 2016 E89R
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 22, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 22, 2015 REAP
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 29, 2015 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 19, 2012 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 19, 2012 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 19, 2012 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Aug 27, 2012 815F
TEAS SECTION 8 & 15 RECEIVED
Aug 27, 2012 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 8, 2012 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 12, 2007 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 8, 2006 ASGN
REGISTERED-PRINCIPAL REGISTER
Aug 29, 2006 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jul 14, 2006 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 28, 2006 ETOF
PUBLISHED FOR OPPOSITION
Feb 28, 2006 PUBO
NOTICE OF PUBLICATION
Feb 8, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 19, 2006 PREV
ASSIGNED TO LIE
Jan 19, 2006 ALIE
ASSIGNED TO LIE
Nov 18, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 11, 2005 CNSA
AMENDMENT FROM APPLICANT ENTERED
Oct 16, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2005 CRFA
PAPER RECEIVED
Oct 5, 2005 MAIL
AMENDMENT FROM APPLICANT ENTERED
Sep 21, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2005 CRFA
PAPER RECEIVED
Jul 5, 2005 MAIL
NON-FINAL ACTION E-MAILED
Jan 6, 2005 GNRT
NON-FINAL ACTION WRITTEN
Jan 6, 2005 CNRT
ASSIGNED TO EXAMINER
Jan 6, 2005 DOCK
NEW APPLICATION ENTERED
Jun 9, 2004 NWAP